2m 2m 2m 2m 2m 2m 2m
CAPRICOR THERAP (CAPR)
NASDAQ
$6.11+$0.23 (+3.86%)
Price as of Oct 22, 2026 7:57 PM EDT- $341.9MMarket Cap
- -5.62%1-Year Change
- BiotechnologyIndustry
CAPRICOR THERAP (CAPR)
$6.11+$0.23 (+3.86%)
CAPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.88 | ||
Change | -$0.73 (-11.04%) | ||
Open | $6.60 | ||
High | $6.75 | ||
Low | $5.79 | ||
Previous Close | $6.61 | ||
Volume | 3,440,920 | ||
30-Day Average Volume | 3,505,835 | ||
1-Week Change | -10.77% | ||
1-Month Change | -33.93% | ||
1-Year Change | -5.62% | ||
3-Year Change | 113.04% | ||
5-Year Change | 47.37% | ||
Fundamentals | |||
Shares Outstanding | 58.1M | ||
Total Assets | $368.7M | ||
Market Cap | $341.9M | ||
Enterprise Value | $320.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$40.7M | ||
Free Cash Flow | -$35.5M | ||
EBIT | -$40.7M | ||
EBITDA | -$40.2M | ||
Net Working Capital | $209.2M | ||
EPS | -$0.70 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/05/2019 | ||
Earnings & Revenue